CJJD - China Jo - Jo Drugstores GAAP EPS of -$0.92 revenue of $164.39M
- China Jo - Jo Drugstores press release ( NASDAQ: CJJD ): FY GAAP EPS of -$0.92.
- Revenue of $164.39M (+23.5% Y/Y).
- Revenue increased by 23.5% to $164.39 million for the fiscal year ended March 31, 2022 from $133.13 million for the same period of last year.
- Gross profit increased by 24.9% to $36.52 million for the fiscal year ended March 31, 2022 from $29.24 million for the same period of last year.
- Gross margin increased by 0.2 percentage points to 22.2% for the fiscal year ended March 31, 2022 from 22.0% for the same period of last year.
-
Revenue for the fiscal year ended March 31, 2022 increased by $31.25 million, or 23.5%, to $164.39 million from $133.13 million for the same period of last year. The increase in revenue was primarily due to the growth in retail drugstores, online pharmacy and wholesale business.
For further details see:
China Jo - Jo Drugstores GAAP EPS of -$0.92, revenue of $164.39M